FDA grants breakthrough designation to EMD Serono's lupus drug enpatoran

July 8, 2026 8:00 AM

EMD Serono, the U.S. and Canada healthcare unit of Merck KGaA, Darmstadt, Germany, announced that the U.S. Food and Drug ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found